These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2212149)

  • 21. Which first-line treatment for cutaneous sarcoidosis? A retrospective study of 120 patients.
    Cohen E; Lheure C; Ingen-Housz-Oro S; Hotz C; Bettuzzi T; Chasset F; Descamps V; Deschamps L; Mahevas M; Terrier B; Sohier P; Guegan S; Kramkimel N; Darbord D; Chanal J; Oulès B; Aractingi S; Seta V; Dupin N
    Eur J Dermatol; 2023 Dec; 33(6):680-685. PubMed ID: 38465550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of generalized granuloma annulare responding to hydroxychloroquine.
    Frankel DH; Medenica MM; Lorincz AL
    Cleve Clin J Med; 1988; 55(2):117. PubMed ID: 2968198
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and histopathological analysis of specific lesions of cutaneous sarcoidosis in Korean patients.
    Jung YJ; Roh MR
    J Dermatolog Treat; 2011 Feb; 22(1):11-7. PubMed ID: 20524878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleomorphic cutaneous sarcoidosis confined to lesions of vitiligo vulgaris in a patient with type 1 diabetes mellitus.
    Chhabra N; Pandhi D; Verma P; Singal A
    Indian J Dermatol Venereol Leprol; 2012; 78(6):754-6. PubMed ID: 23075651
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of sarcoidosis in cosmetic tattoos.
    Antonovich DD; Callen JP
    Arch Dermatol; 2005 Jul; 141(7):869-72. PubMed ID: 16027303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.
    Wu JH; Imadojemu S; Caplan AS
    Am J Clin Dermatol; 2022 Jul; 23(4):499-514. PubMed ID: 35583850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gastric sarcoidosis revealed by cutaneous follicular sarcoidosis].
    Demongeot C; Moulonguet I; Georges P; Bagot M; Flageul B
    Ann Dermatol Venereol; 2011 Feb; 138(2):116-9. PubMed ID: 21333822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine treatment of porphyria cutanea tarda.
    Malkinson FD; Levitt L
    Arch Dermatol; 1980 Oct; 116(10):1147-50. PubMed ID: 7425660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
    Paolino A; Galloway J; Birring S; Brex P; Larkin G; Patel A; Sado D; Murgatroyd F; Walsh S
    Clin Exp Dermatol; 2021 Aug; 46(6):1038-1045. PubMed ID: 33608920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous sarcoidosis: an intriguing model of immune dysregulation.
    Ruocco E; Gambardella A; Langella GG; Lo Schiavo A; Ruocco V
    Int J Dermatol; 2015 Jan; 54(1):1-12. PubMed ID: 25312788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective analysis of 34 patients with cutaneous sarcoidosis assessed in a dermatology department.
    Collin B; Rajaratnam R; Lim R; Lewis H
    Clin Exp Dermatol; 2010 Mar; 35(2):131-4. PubMed ID: 19594768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thalidomide for improving cutaneous and pulmonary sarcoidosis in patients resistant or with contraindications to corticosteroids.
    Fazzi P; Manni E; Cristofani R; Cei G; Piazza S; Calabrese R; Antonelli A; Siciliano G; Barachini P; Carpi A
    Biomed Pharmacother; 2012 Jun; 66(4):300-7. PubMed ID: 22494798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous Sarcoidosis.
    Wanat KA; Rosenbach M
    Clin Chest Med; 2015 Dec; 36(4):685-702. PubMed ID: 26593142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle involvement in sarcoidosis: a retrospective and followup studies.
    Fayad F; Lioté F; Berenbaum F; Orcel P; Bardin T
    J Rheumatol; 2006 Jan; 33(1):98-103. PubMed ID: 16395757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized ulcerative sarcoidosis.
    Schwartz RA; Robertson DB; Tierney LM; McNutt NS
    Arch Dermatol; 1982 Nov; 118(11):931-3. PubMed ID: 7138054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.
    Sharma OP
    Arch Neurol; 1998 Sep; 55(9):1248-54. PubMed ID: 9740120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cutaneous sarcoidosis through a hospital series of 28 cases].
    Ben Jennet S; Benmously R; Chaâbane S; Fenniche S; Marrak H; Mohammed Z; Mokhtar I
    Tunis Med; 2008 May; 86(5):447-50. PubMed ID: 19469298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orbital sarcoidosis treated with hydroxychloroquine.
    Rabinowitz MP; Murchison AP
    Orbit; 2011 Jan; 30(1):13-5. PubMed ID: 21281071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.